IRIC - Institute for Research in Immunology and Cancer

Scientific Conferences - Fall 2026

September 14—December 13, 2026

IRIC presents the 41^st edition of its scientific lecture series—Fall 2026.

Science at the heart of Summer Interns’ Scientific Day at IRIC!

The 8^th IRIC Summer Summer Interns’ Scientific Day once again showcased the talent, creativity, and dedication of our young scientists. The event was organized by the IRIC Office of Academic Affairs in collaboration with summer interns.

Nearly $2 million in funding for the acquisition of state-of-the-art equipment at IRIC

The Canada Foundation for Innovation (CFI) recently announced the results of its John R. Evans Leaders Fund competition. This program enables universities to attract and retain world-class researchers in Canada by providing them with state-of-the-art infrastructure. The CFI’s funding is supplemented by the Government of Quebec and other partners. Two IRIC projects have been awarded grants through this program.

The Natural Sciences and Engineering Research Council of Canada Funds Two IRIC Projects

The Natural Sciences and Engineering Research Council of Canada (NSERC) recently awarded its 2026 Discovery Grants. This program aims to support ongoing research programs with long-term goals. Two IRIC projects have been awarded these grants.

The Canadian Institutes of Health Research Funds Two Projects from Guy Sauvageau’s Laboratory

The Canadian Institutes of Health Research (CIHR) recently awarded grants for the Project program as part of the Spring 2026 competition. Two projects from IRIC’s Molecular Genetics of Stem Cells Research Unit, led by Guy Sauvageau, received funding.

Ribosomal Dysfunction as an Oncogenic Driver in Certain Leukemias

The team led by Guy Sauvageau, director of IRIC’s Molecular Genetics of Stem Cells Research Unit, has identified a subtype of acute myeloid leukemia (AML) characterized by a significant reduction in the cells’ ability to produce proteins resulting from the loss of several ribosomal genes. This study, which proposes a new conceptual model of leukemogenesis, paves the way for the identification of new biomarkers and a new therapeutic vulnerability. Led by Principal Research Advisor Jean-François Spinella, this work is published in the journal Science Advances.